Won Yeo Kyoung, Yoo Young-Sik, Yun Hee-Jee, Chung Tae-Young, Lim Dong Hui
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
IU Eye Clinic, Seoul 05606, Republic of Korea.
J Clin Med. 2024 Nov 13;13(22):6815. doi: 10.3390/jcm13226815.
This study aimed to analyze the accuracy of the SRK/T, Haigis, Barrett Universal II (BUII), Kane, and EVO intraocular lens (IOL) formulas for normal and long axial length (AL) groups using an ARGOS (Alcon, Fort Worth, TX, USA), which uses the specific refractive indices. We performed a review of patients who underwent uneventful cataract surgery with the implantation of an Acrysof IQ SN60WF IOL (Alcon, Inc.) between January 2020 and December 2021. Biometry was obtained with the ARGOS; patients were separated into subgroups based on AL as follows: normal (22.0 ≤ AL < 26.0 mm) and long (AL ≥ 26.0 mm). Outcomes included the mean error (ME), the mean absolute error (MAE), the median absolute error (MedAE), and the proportion of eyes within ±0.25, ±0.50, ±0.75, and ±1.00 diopters (D) of the prediction error. A total of 191 eyes of 191 patients were included: 162 eyes of 162 patients in the normal AL group and 29 eyes of 29 patients in the long AL group. The EVO formula was the most accurate for the normal AL group, which had the lowest MAE and MedAE. The MAE and MedAE of EVO were the lowest in the long AL group; EVO showed the highest percentage of eyes within ±0.25, ±0.75, and 1.00 D compared with other formulas. When using an ARGOS, the EVO formula had the lowest MAE and the highest proportion of eyes within ±1.00 D of the predicted target in both the normal and high myopia groups.
本研究旨在使用采用特定折射率的ARGOS(爱尔康公司,美国得克萨斯州沃思堡),分析SRK/T、Haigis、巴雷特通用二代(BUII)、凯恩和EVO人工晶状体(IOL)公式在正常眼轴长度(AL)组和长眼轴长度组中的准确性。我们回顾了2020年1月至2021年12月期间接受了平稳白内障手术并植入了Acrysof IQ SN60WF IOL(爱尔康公司)的患者。使用ARGOS进行生物测量;患者根据AL分为以下亚组:正常组(22.0≤AL<26.0mm)和长眼轴组(AL≥26.0mm)。结果包括平均误差(ME)、平均绝对误差(MAE)、中位数绝对误差(MedAE)以及预测误差在±0.25、±0.50、±0.75和±1.00屈光度(D)范围内的眼比例。共纳入191例患者的191只眼:正常AL组162例患者的162只眼和长AL组29例患者的29只眼。EVO公式在正常AL组中最准确,该组的MAE和MedAE最低。在长AL组中,EVO的MAE和MedAE最低;与其他公式相比,EVO在±0.25、±0.75和1.00 D范围内的眼比例最高。在使用ARGOS时,EVO公式在正常组和高度近视组中均具有最低的MAE以及预测目标±1.00 D范围内最高的眼比例。